For the Inventor, By the Inventor

Enter assignee name

Raleigh, NC, United States of America

Micell Technologies, Inc.

USPTO Granted Patents = 105

% Expired Patents = 29.5

CIPO Patents = 26

EPO Patents = 20

Forward Citations = 1,351

Loading Chart...

Loading Chart...

47 inventors (with patents filed for the assignee):

James B McClain (86 out of 104 patents)

James P DeYoung (50 out of 62 patents)

Timothy J Romack (30 out of 50 patents)

4. Charles Douglas Taylor (18 out of 23 patents)

5. Stephen M Gross (11 out of 11 patents)

6. David E Brainard (11 out of 12 patents)

7. Mark Wagner (10 out of 10 patents)

8. Michael E Cole (9 out of 10 patents)

9. Clint Smoke (8 out of 10 patents)

10. Mike Cole (8 out of 10 patents)

11. Doug Taylor (8 out of 9 patents)

12. Gina M Stewart (8 out of 8 patents)

13. Steve Worm (7 out of 10 patents)

14. Gary C Schrebe (7 out of 7 patents)

15. Steven Lee Worm (7 out of 47 patents)

Core Competencies:

Bioabsorbable Implants

Drug Delivery Devices

Polymer Coatings

Controlled Morphology

Stents

Biodegradable Layers

Drug-Eluting Coatings

Extracellular Matrix

Macrolide Dosage Forms

Surgical Sutures

Microelectronic Substrates

Carbon Dioxide Cleaning

105 patents: Sort by Forward Citations

1. 11039943 - Bioabsorbable biomedical implants (2021-06-22),

2. 11007307 - Coatings containing multiple drugs (2021-05-18),

3. 10898353 - Polymer coatings containing drug powder of controlled morphology (2021-01-26),

4. 10835396 - Stent with polymer coating containing amorphous rapamycin (2020-11-17),

5. 10729819 - Drug delivery medical device (2020-08-04),

6. 10653820 - Coated stents (2020-05-19),

7. 10617795 - Stents having biodegradable layers (2020-04-14),

8. 10464100 - System and process for formation of a time-released, drug-eluting transferable coating (2019-11-05),

9. 10350391 - Drug delivery medical device (2019-07-16),

10. 10350333 - Stents having bioabsorable layers (2019-07-16),

11. 10293050 - Macrolide dosage forms (2019-05-21),

12. 10272606 - Bioabsorbable biomedical implants (2019-04-30),

13. 10232092 - Stents and other devices having extracellular matrix coating (2019-03-19),

14. 10188772 - Drug delivery medical device (2019-01-29),

15. 10117972 - Drug delivery medical device (2018-11-06),

Micell Technologies, Inc., based in Raleigh, NC, specializes in the development of advanced biomedical coatings, focusing on bioabsorbable implants and drug delivery devices. The company is dedicated to innovating polymer coatings that enhance the performance of medical devices, including stents and other implantable technologies. Their expertise in controlled morphology and biodegradable layers enables the creation of drug-eluting coatings that improve therapeutic outcomes. Micell's commitment to advancing healthcare through cutting-edge materials science positions it as a leader in the biomedical field.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

105 Patents

#7 in Raleigh, NC

#95 in North Carolina

#3,619 in US

#7,446 in the World

Raleigh, NC, United States of America

Micell Technologies, Inc.

Forward Citations = 1,351

47 inventors:

James B McClain (86 out of 104 patents)

James P DeYoung (50 out of 62 patents)

Timothy J Romack (30 out of 50 patents)

4. Charles Douglas Taylor (18 out of 23 patents)

5. Stephen M Gross (11 out of 11 patents)

Please report any incorrect information to [email protected]

Loading…